Lee Colin, Walker Sandra A N, Palmay Lesley, Walker Scott E, Tobe Sheldon, Simor Andrew
Sunnybrook Health Sciences Centre, Department of Pharmacy, Toronto, ON, Canada.
University of Toronto, Leslie L. Dan Faculty of Pharmacy, Toronto, ON, Canada.
Perit Dial Int. 2018 Jan-Feb;38(1):73-76. doi: 10.3747/pdi.2017.00052.
Steady-state pharmacokinetics of oral ciprofloxacin in 3 continuous cycling peritoneal dialysis (CCPD) outpatients given ciprofloxacin 750 mg b.i.d. for 5 doses was determined. Mean steady-state maximum serum concentration and half-life were 4.4 ± 1.5 mg/L and 10.3 ± 2.6 hours, respectively. Mean maximum dialysate concentration in the daytime long dwell and overnight continuous cycling dwell were 7.4 ± 1.2 mg/L and 3.3 ± 1.2 mg/L, respectively. Oral ciprofloxacin 750 mg b.i.d. may be reasonable for bloodstream and peritoneal infections caused by susceptible bacteria in CCPD patients.
测定了3例持续循环腹膜透析(CCPD)门诊患者口服环丙沙星750毫克,每日两次,共5剂后的稳态药代动力学。平均稳态最大血清浓度和半衰期分别为4.4±1.5毫克/升和10.3±2.6小时。白天长时间留腹和夜间持续循环留腹时的平均最大透析液浓度分别为7.4±1.2毫克/升和3.3±1.2毫克/升。对于CCPD患者由易感细菌引起的血流和腹膜感染,口服环丙沙星750毫克,每日两次可能是合理的。